The stock of Sotera Health Co (SHC) has seen a -5.87% decrease in the past week, with a -24.98% drop in the past month, and a -26.82% decrease in the past quarter. The volatility ratio for the week is 2.61%, and the volatility levels for the past 30 days are at 4.61% for SHC. The simple moving average for the last 20 days is -7.04% for SHC stock, with a simple moving average of -28.76% for the last 200 days.
Is It Worth Investing in Sotera Health Co (NASDAQ: SHC) Right Now?
The price-to-earnings ratio for Sotera Health Co (NASDAQ: SHC) is 59.82x, which is above its average ratio. Moreover, the 36-month beta value for SHC is 2.11. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for SHC is 126.48M and currently, short sellers hold a 8.59% of that float. On April 18, 2024, SHC’s average trading volume was 1.77M shares.
SHC) stock’s latest price update
Sotera Health Co (NASDAQ: SHC)’s stock price has decreased by -1.29 compared to its previous closing price of 10.89. However, the company has seen a -5.87% decrease in its stock price over the last five trading sessions. GlobeNewsWire reported 2024-04-11 that CLEVELAND, April 11, 2024 (GLOBE NEWSWIRE) — Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the first-quarter ended March 31, 2024 before the market opens on Thursday, May 2, 2024. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company’s operating highlights and financial results.
Analysts’ Opinion of SHC
Many brokerage firms have already submitted their reports for SHC stocks, with Citigroup repeating the rating for SHC by listing it as a “Buy.” The predicted price for SHC in the upcoming period, according to Citigroup is $16 based on the research report published on April 03, 2024 of the current year 2024.
Jefferies, on the other hand, stated in their research note that they expect to see SHC reach a price target of $15.50, previously predicting the price at $15. The rating they have provided for SHC stocks is “Buy” according to the report published on March 25th, 2024.
SHC Trading at -22.33% from the 50-Day Moving Average
After a stumble in the market that brought SHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -44.59% of loss for the given period.
Volatility was left at 4.61%, however, over the last 30 days, the volatility rate increased by 2.61%, as shares sank -18.00% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -29.04% lower at present.
During the last 5 trading sessions, SHC fell by -5.87%, which changed the moving average for the period of 200-days by -42.94% in comparison to the 20-day moving average, which settled at $11.45. In addition, Sotera Health Co saw -36.20% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SHC starting from WARBURG PINCUS & CO., who sale 16,594,363 shares at the price of $14.31 back on Mar 04 ’24. After this action, WARBURG PINCUS & CO. now owns 88,822,952 shares of Sotera Health Co, valued at $237,423,849 using the latest closing price.
WARBURG PINCUS & CO., the Director of Sotera Health Co, sale 16,594,363 shares at $14.31 during a trade that took place back on Mar 04 ’24, which means that WARBURG PINCUS & CO. is holding 88,822,952 shares at $237,423,849 based on the most recent closing price.
Stock Fundamentals for SHC
Current profitability levels for the company are sitting at:
- 0.28 for the present operating margin
- 0.54 for the gross margin
The net margin for Sotera Health Co stands at 0.05. The total capital return value is set at 0.1. Equity return is now at value 12.85, with 1.63 for asset returns.
Based on Sotera Health Co (SHC), the company’s capital structure generated 0.83 points at debt to capital in total, while cash flow to debt ratio is standing at -0.07. The debt to equity ratio resting at 5.06. The interest coverage ratio of the stock is 2.35.
Currently, EBITDA for the company is 516.81 million with net debt to EBITDA at 5.19. When we switch over and look at the enterprise to sales, we see a ratio of 4.83. The receivables turnover for the company is 5.98for trailing twelve months and the total asset turnover is 0.34. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.42.
Conclusion
To wrap up, the performance of Sotera Health Co (SHC) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
